These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 20022377

  • 1. Pairwise decomposition of residue interaction energies of single chain Fv with HIV-1 p17 epitope variants.
    Lee VS, Tue-ngeun P, Nangola S, Kitidee K, Jitonnom J, Nimmanpipug P, Jiranusornkul S, Tayapiwatana C.
    Mol Immunol; 2010 Feb; 47(5):982-90. PubMed ID: 20022377
    [Abstract] [Full Text] [Related]

  • 2. Improved scFv anti-HIV-1 p17 binding affinity guided from the theoretical calculation of pairwise decomposition energies and computational alanine scanning.
    Tue-ngeun P, Kodchakorn K, Nimmanpipug P, Lawan N, Nangola S, Tayapiwatana C, Rahman NA, Zain SM, Lee VS.
    Biomed Res Int; 2013 Feb; 2013():713585. PubMed ID: 24308004
    [Abstract] [Full Text] [Related]

  • 3. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S, Marini E, Bozzo L, Trainini L, Saadoune L, Avolio M, Pontillo A, Bonfanti C, Sarmientos P, Caruso A.
    Biopolymers; 2004 Feb; 76(4):334-43. PubMed ID: 15386266
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D, Notkins AL, Zhou P.
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [Abstract] [Full Text] [Related]

  • 5. Solution X-ray scattering reveals a novel structure of calmodulin complexed with a binding domain peptide from the HIV-1 matrix protein p17.
    Izumi Y, Watanabe H, Watanabe N, Aoyama A, Jinbo Y, Hayashi N.
    Biochemistry; 2008 Jul 08; 47(27):7158-66. PubMed ID: 18553937
    [Abstract] [Full Text] [Related]

  • 6. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
    Tewari D, Goldstein SL, Notkins AL, Zhou P.
    J Immunol; 1998 Sep 01; 161(5):2642-7. PubMed ID: 9725267
    [Abstract] [Full Text] [Related]

  • 7. Enhanced production of functional extracellular single chain variable fragment against HIV-1 matrix protein from Escherichia coli by sequential simplex optimization.
    Intachai K, Singboottra P, Leksawasdi N, Kasinrerk W, Tayapiwatana C, Butr-Indr B.
    Prep Biochem Biotechnol; 2015 Sep 01; 45(1):56-68. PubMed ID: 24884357
    [Abstract] [Full Text] [Related]

  • 8. Redesigning of anti-c-Met single chain Fv antibody for the cytoplasmic folding and its structural analysis.
    Edwardraja S, Neelamegam R, Ramadoss V, Venkatesan S, Lee SG.
    Biotechnol Bioeng; 2010 Jun 15; 106(3):367-75. PubMed ID: 20178123
    [Abstract] [Full Text] [Related]

  • 9. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G.
    Rev Argent Microbiol; 2004 Jun 15; 36(4):151-7. PubMed ID: 15786866
    [Abstract] [Full Text] [Related]

  • 10. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
    Kageyama S, Katsumoto T, Taniguchi K, Ismail SI, Shimmen T, Sasao F, Gao M, Owatari S, Wakamiya N, Tsuchie H, Ueda S, Shiraki K, Kurimura T.
    Acta Virol; 1996 Sep 15; 40(4):195-200. PubMed ID: 9014009
    [Abstract] [Full Text] [Related]

  • 11. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.
    Fiorentini S, Giagulli C, Caccuri F, Magiera AK, Caruso A.
    Pharmacol Ther; 2010 Dec 15; 128(3):433-44. PubMed ID: 20816696
    [Abstract] [Full Text] [Related]

  • 12. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p17 of B- and C-subtypes.
    Gupta S, Arora K, Gupta A, Chaudhary VK.
    Protein Expr Purif; 2001 Apr 15; 21(3):378-85. PubMed ID: 11281711
    [Abstract] [Full Text] [Related]

  • 13. Docking and free energy simulations to predict conformational domains involved in hCG-LH receptor interactions using recombinant antibodies.
    Majumdar R, Railkar R, Dighe RR.
    Proteins; 2011 Nov 15; 79(11):3108-22. PubMed ID: 21989932
    [Abstract] [Full Text] [Related]

  • 14. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 15. Epitope mapping by mass spectrometry: determination of an epitope on HIV-1 IIIB p26 recognized by a monoclonal antibody.
    Parker CE, Papac DI, Trojak SK, Tomer KB.
    J Immunol; 1996 Jul 01; 157(1):198-206. PubMed ID: 8683115
    [Abstract] [Full Text] [Related]

  • 16. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ, Vyakarnam A, Cheingsong-Popov R, Callow D, Jones KL, Senior JM, Adams SE, Kingsman AJ, Matear P, Gotch FM.
    AIDS; 1993 Oct 01; 7(10):1315-23. PubMed ID: 8267904
    [Abstract] [Full Text] [Related]

  • 17. Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17.
    Fiorentini S, Marsico S, Becker PD, Iaria ML, Bruno R, Guzmán CA, Caruso A.
    Vaccine; 2008 Aug 26; 26(36):4758-65. PubMed ID: 18602957
    [Abstract] [Full Text] [Related]

  • 18. Slight difference in primary amino acid sequence of p17 matrix protein of HIV-1 exerts profound influence on its antigenicity.
    Taniguchi K, Tsuchie H, Kageyama S, Iwasaki M, Takagi T, Sasao F, Ueda S, Kurimura T.
    Arch Virol; 1998 Aug 26; 143(5):881-90. PubMed ID: 9645195
    [Abstract] [Full Text] [Related]

  • 19. Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia.
    Tsiakalos A, Routsias JG, Kordossis T, Moutsopoulos HM, Tzioufas AG, Sipsas NV.
    J Infect Dis; 2011 Sep 15; 204(6):902-11. PubMed ID: 21849287
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X, Campoli M, Ko E, Luo W, Ferrone S.
    J Immunol Methods; 2004 Nov 15; 294(1-2):23-35. PubMed ID: 15604013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.